The Sleep Apnea Device Market has a Bright Future

I have some exciting news to share! The sleep apnea device market has a bright future and that’s great news for us dentists! So, what’s the outlook? Well, by 2020 it is estimated to reach a worth of about $5.3 billion. In the report “Sleep Apnea Devices Market by Product, Diagnostic (PSG, Pulse Oximeter), Therapeutic [CPAP, APAP, BPAP, Masks (Full Face Mask), Oral Appliances (Mandibular Advancement Device)], End User (Home Care Settings, Hospitals) – Analysis & Global Forecasts to 2020”, the major market drivers, restraints/challenges, and opportunities were analyzed and studied.

In the report, as presented by marketsandmarkets.com, the global sleep apnea devices market is studied for the forecast period of 2015-2020. As of 2015, the market was at $3.7 billion, but by 2020, the market is expected to reach $5.3 billion at a CAGR of 7.2% during the forecast period. With 2015 being the highest growth of the market, we will continue to see a growth spurt at the highest rate yet.

A Look at the Forecast

The regions for this study included the following areas:

  • North America
  • Europe
  • Asia-Pacific
  • The Rest of the World (Latin America, Central America, and Africa)

We saw North America with the largest share in the sleep apnea market in 2015, followed by Europe and Asia-Pacific. However, the European market has projections to grow at the highest CAGR rate during the target between now and 2020.

ResMed, a major player in the market, continues to observe a strong focus on innovation. Through such a rich pipeline of innovative products in the market opens up so many opportunities for treatment of sleep apnea.

Remain ahead of the game by providing the best treatment options for sleep apnea through oral appliance therapy. Together we can help our patients get a better night’s sleep. To learn more about sleep apnea and available treatment options, visit www.mpateldds.com. You can also view upcoming lectures to help you continue to learn more about this growing industry.

Oral Appliance Study Displays Success

We never needed further proof of the success of oral appliance therapy, but it doesn’t hurt to hear more about it and reaffirm its input. In this recent study, we can see just how successful Narval appliances are in the treatment of sleep apnea. Let’s take a look…

The Background

In this study, mandibular repositioning devices (MRDs) are usually recommended as the first form of therapy for patients suffering from mild to moderate obstructive sleep apnea (OSA). Unfortunately, though, data on the long-term efficacy of MRDs hasn’t been readily available. This is not only true for patients with OSA who are noncompliant with CPAP, but also in those with more severe OSA.

To get a better understanding of the success of oral appliances, such as MRDs and the Narval appliance, the ORCADES study[1] aimed to determine the long-term efficiency and tolerability of two custom-made Narval MRDs for the treatment of OSA patients. The study was completed over a three to six month period of time.

Eligible patients suffering from OSA who also refused or were CPAP noncompliant, were studied. The outcomes were measured after gradual mandibular advancement titration, which included AHI, oxygen saturation, sleepiness, symptoms, quality of life, side effects and compliance. And, drumroll please! Here are the results…

The Results

Of a total of 369 patients involved in the study, overall MRD treatment was successful in approximately 76%. Additionally, complete response to treatment with MRDs was achieved in 64% of participants.

The study also treated severe OSA with MRDs, and about 60% of the participants were effectively treated with about 38% having completed symptoms resolution. As a result, the use of MRDs in the treatment of sleep apnea significantly decreased a person’s sleepiness, and eliminated symptoms while improving their quality of life. Treatment with MRDs were very well tolerated and compliance was at its highest rate.

Custom-made appliances, such as Narval MRDs, are effective forms of treatment for mild to severe OSA, as well as for patients who are CPAP noncompliant. Keep this study in mind when informing your patients of proper treatment options, as well as sharing with referring doctors.

 

 

 

 

[1]  Vecchierini, M. F., Attali, V., Collet, J. M., d’Ortho, M. P., El Chater, P., Kerbrat, J. B., … & Mullens, E. (2016). A custom-made mandibular repositioning device for obstructive sleep apnoea–hypopnoea syndrome: the ORCADES study. Sleep Medicine, 19, 131-140.